Menu
1-702-720-6310 info@microcapspecualtors.com

Upsized offering delivers $100M payoff to argenx as another biotech joins the IPO parade – Endpoints News


Endpoints News

Upsized offering delivers $100M payoff to argenx as another biotech joins the IPO parade
Endpoints News
The Dutch antibody shop argenx is the latest biotech to join the growing IPO parade on Nasdaq. The biotech raised $100 million on the sale of 5.9 million shares at $17 each. And that reflects an increase of more than 2 million shares over what the

and more »

Search